VEGF plays an essential role in regulating angiogenesis of glioma and, thus, anti-angiogenesis therapy targeting the VEGF signaling pathway has been recognized as an effective targeted therapy method for malignant glioma (2, 3). The gene discussed is VEGFA; the disease is glioma.